• Serotonin, Serum
  • Arsenic Fractionation, 24 Hour, Urine
  • Albumin Random, Urine
  • Diazepam, Urine
  • Endometrial Stromal Tumors (EST), 7p15 (JAZF1), 6p21.32 (PHF1), 17p13.3 (YWHAE) Rearrangement, FISH, Tissue
  • Plasminogen Activity, Plasma
  • 11-Dehydro-Thromboxane B2, Urine
  • Herpesvirus 7 (HHV-7) DNA, Qualitative or Quantitative
  • Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
  • Lysosomal Acid Lipase, Gene Variation
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Interpretation
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.
Loading...